Treatment Options for Male Anorgasmia
For male anorgasmia, treatment should focus on psycho-behavioral strategies combined with pharmacological approaches, with first-line interventions including vibratory therapy, testosterone replacement when indicated, and modification of sexual practices to increase arousal. 1, 2
Diagnostic Considerations
Before initiating treatment, identify potential causes:
- Medication-induced: Review current medications, particularly SSRIs, antidepressants, and antihypertensives
- Hormonal: Check morning testosterone levels (consider replacement if <300 ng/dL)
- Neurological: Assess for underlying neuropathy or neurological conditions
- Psychological: Evaluate for anxiety, depression, relationship issues, or sexual trauma
Treatment Algorithm
First-Line Approaches
Modify sexual practices to enhance arousal 1
- Change sexual positions or incorporate alternative sexual practices
- Improve communication between partners about sexual needs
- Consider sexual enhancement devices
- Particularly effective for neurological causes of anorgasmia
- Can be used as home-based therapy with proper instruction
- If total morning testosterone <300 ng/dL, consider testosterone replacement therapy
- Monitor for improvement in sexual function and potential side effects
Referral to sexual health specialist 1, 2
- Mental health professional with expertise in sexual health
- Psycho-behavioral strategies can enhance arousal and remove inhibitions
Second-Line Pharmacological Options
If first-line approaches fail, consider these pharmacological interventions 1:
| Medication | Dosage | Timing |
|---|---|---|
| Oxytocin | 24 IU intranasal/sublingual | During sexual activity |
| Pseudoephedrine | 60-120 mg | 120-150 minutes before sex |
| Ephedrine | 15-60 mg | 1 hour before sex |
| Midodrine | 5-40 mg | 30-120 minutes before sex |
| Bethanecol | 20 mg daily | - |
| Yohimbine | 5.4 mg three times daily | - |
| Cabergoline | 0.25-2 mg twice weekly | - |
| Imipramine | 25-75 mg daily | - |
For Medication-Induced Anorgasmia
- Consider dose adjustment, staged cessation, or medication substitution 1
- If SSRIs are the cause, consider:
- Dose reduction if clinically appropriate
- Drug holidays (with physician supervision)
- Switching to medications with lower sexual side effect profiles
For Psychogenic Anorgasmia
- Cognitive-behavioral therapy focused on sexual function
- Mindfulness-based approaches to reduce performance anxiety
- Address relationship issues that may contribute to sexual dysfunction
Special Considerations
- PDE5 inhibitors: May help with orgasmic problems, particularly when mild erectile dysfunction coexists 1
- Pelvic physical therapy: Can improve pelvic floor function and sensation 1, 2
- Experimental treatments: Flibanserin has shown promise in case reports but requires further study 4
Monitoring and Follow-up
- Evaluate response to therapy after 4-12 weeks
- Consider alternative approaches if initial treatment fails
- Reassess using validated questionnaires when available
Important Caveats
- Most pharmacological treatments for anorgasmia are off-label and not FDA-approved 2, 5
- Treatment success varies significantly between individuals 1
- Combined approaches (psychological and pharmacological) typically yield better results than either modality alone 1, 6
- Avoid surgical interventions as they should be considered experimental 1
The management of male anorgasmia remains challenging due to its multifactorial nature and the lack of FDA-approved treatments specifically for this condition. A stepwise approach starting with non-pharmacological interventions and progressing to pharmacotherapy when needed offers the best chance for improvement.